SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-008251
Filing Date
2023-03-16
Accepted
2023-03-16 14:03:46
Documents
57
Period of Report
2023-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q csbr-20230131.htm   iXBRL 10-Q 806323
2 EX-31.1 csbrq3131202310-qex311.htm EX-31.1 10882
3 EX-31.2 csbrq3131202310-qex312.htm EX-31.2 10982
4 EX-32.1 csbrq3131202310-qex321.htm EX-32.1 8018
  Complete submission text file 0001628280-23-008251.txt   4342053

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20230131.xsd EX-101.SCH 33224
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT csbr-20230131_cal.xml EX-101.CAL 46855
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20230131_def.xml EX-101.DEF 119314
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20230131_lab.xml EX-101.LAB 418509
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20230131_pre.xml EX-101.PRE 252436
51 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20230131_htm.xml XML 605396
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-11504 | Film No.: 23738274
SIC: 2836 Biological Products, (No Diagnostic Substances)